Roche’s PiaSky wins US approval for PNH | Biotechnology | The Pharmaletter | The Pharmaletter The Pharma LetterRoche gets USFDA nod for chronic blood disorder treatment Crovalimab Medical DialoguesVanEck sets 0.20% fee for proposed spot ethereum ETF XMAfter Asian successes, Roche’s rare blood disease drug gets first FDA approval FirstWord PharmaUS FDA approves Roche’s drug for a chronic blood disorder XM
Read More…
Source: https://www.thepharmaletter.com/roche-s-piasky-wins-us-approval-for-pnh